Scripps Research scientists receive up to $12M to create universal vaccine for alphaviruses Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S.
December 04, 2024
LA JOLLA, CA Alphaviruses often cause a range of illnesses that lead to fever, rash and debilitating joint pain. While they're historically prevalent in tropical and subtropical regions of the world where virus-transmitting mosquitos are abundant, these mosquitos are expanding to new terrain including the U.S. as global warming intensifies. Alphavirus diseases like eastern equine encephalitis, which inflames the brain and can lead to death, are among the country's emerging threats against which no human vaccine is available.
Despite various efforts in the works to develop vaccines for specific alphaviruses, there's currently no universal vaccine to broadly target a range of virus strains. That means as alphaviruses become more widespread, people will need several jabs rather than one assuming specific vaccines become available.
Now, a collaboration among Scripps Research, Vanderbilt University and others has been awarded more than $46 million from the Advanced Research Projects Agency for Health (ARPA-H), a research funding agency of the U.S. government, to develop a universal vaccine against alphaviruses. Scripps Research will receive up to $12 million for its contribution to the project, which is expected to last five years.
The principal investigators at Scripps Research include Torben Schiffner, PhD, who leads immunogen design at the institute; Darrell Irvine, PhD, a professor in the Department of Immunology and Microbiology; Andrew Ward, PhD, a professor in the Department of Integrative Structural and Computational Biology; and Ian Wilson, PhD, who chairs the Department of Integrative Structural and Computational Biology and is the Hansen Professor of Structural Biology.
This award combines experts in artificial intelligence (AI) with vaccinologists to accomplish a great deal over a short time span, says Schiffner, who is the lead principal investigator on the award at Scripps Research. We're going to hear a lot more about alphaviruses in the future, and there already have been minor outbreaks in the U.S.
The money from ARPA-H will fund a two-stage project: After a three-year preclinical stage to create an immunogen candidate, the molecule will enter a phase 1 clinical trial for two years if it performs well preclinically. An immunogen is a substance that activates the immune system, helping the body recognize and fight harmful agents like viruses. This is a primary step in vaccine development, as scientists design an immunogen to mimic parts of a virus that way, when the resulting vaccine is administered, the body can learn how to defend itself even if it has never been exposed to the actual virus.
The principal investigators at Scripps Research plan to synergize their deep-seated knowledge in vaccinology with AI-expertise at other institutes, chiefly Vanderbilt University. Collaborators at Vanderbilt University Medical Center will isolate alphavirus antibodies from people who have survived alphavirus-related infections, particularly those that protect against different alphaviruses. The team at Scripps Research will use these antibodies to guide vaccine design. Initially, they will determine the structure of antibodies and how they bind to alphaviruses.
We need to understand where broadly protective antibodies attack and bind to the virus, Schiffner says. We can then use this information to design immunogens that focus antibodies onto regions conserved across alphaviruses.
The team has already identified several such cross-protective antibodies, providing valuable blueprints for immunogen design.
Normally, if you try to immunize with an entire virus, most of the antibodies will target regions that aren't conserved among different viruses, so you get a vaccine that only works for a particular strain, Schiffner explains. There are very few regions that seem to be conserved across alphaviruses, and those are the regions that we want to target for broad protection against all alphaviruses.
Next is testing various immunogen designs with computer models that include AI algorithms. If a design seems promising, it's tested in vitro and in vivo.
But the role of AI doesn't end there; data from ensuing in vitro and in vivo experimentation are fed back to the AI system, which can rapidly analyze antibody sequences, determine whether the immunogen is focusing antibodies on regions conserved across variants, and provide improved algorithms for reoptimizing the vaccine design.
We'll find out if the antibodies actually target the regions that they're supposed to, Schiffner says. And once we get the AI results, we can use the information to improve our immunogen before the next stages; it's an iterative process.
The anticipated result: a broad vaccine that targets both encephalitic and arthritogenic alphaviruses that cause brain or joint inflammation, respectively. Moreover, the algorithms developed for this project could potentially be applied to other viruses, including influenza and HIV.
But the main goal is to have an effective, broad vaccines for alphaviruses before they become a major problem. emphasizes Schiffner.
Immunology & Microbiology Integrative Structural & Computational Biology
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
02/06/2026
blueCORE standalone processors headline solutions designed to simplify the trans...
02/06/2026
If you've kept up with this article series, you know by now where to start w...
02/06/2026
With new DSP configurations and flexible licensing options, Calrec is removing the barriers to virtualised audio, giving broadcasters the freedom to scale produ...
02/06/2026
The TV agency was one of the earliest adopters of Nielsen's local television...
02/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/06/2026
Grass Valley today announced that Australian News Channel (ANC), operator of Sky News Australia, has deployed Grass Valley AMPP to transform its newsroom produc...
02/06/2026
Studio Technologies, a leading manufacturer of high-quality audio, video, and fiber-optic solutions, announces its new Model 385 Mic/Intercom Beltpack. The Mode...
02/06/2026
The Riedel Group today announced the appointment of Gudrun Scharler as CEO of Riedel Networks. She succeeds Michael Martens, who has led Riedel Networks since 2...
02/06/2026
More signals, higher quality, and outstanding ingest and streaming flexibility deliver professional results in a small, all-in-one footprint...
02/06/2026
farmerswife will be featured on the Modena Media & Entertainment stand at this year's Mediatech Africa 2026, giving visitors an opportunity to explore the l...
02/06/2026
PTZOptics will showcase a new generation of intelligent video workflows at InfoComm 2026, June 17 19, Las Vegas. Visitors to booth N8227 will see how PTZOptics ...
02/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
02/06/2026
Back to All News
Discover Your Next Book-to-Screen Obsession With Our New Dedicated Hub
Product
02 June 2026
Global
Link copied to clipboard
Dear most vor...
02/06/2026
New LinkedIn Data: 90% of C-Suite Leaders are Continuously Building Skills to Lead in the AI Era Published on Jun 2, 2026 Categories: Data and insights
Lin...
02/06/2026
Trust has become a commercial issue With global advertising spend forecast to exceed US$1 trillion this year*, the commercial consequences of weak governance co...
02/06/2026
June sees Ireland's cultural calendar in full bloom, as RT Supporting the Arts showcases a vibrant and wide-ranging programme spanning music, theatre, visu...
02/06/2026
After The Traitors Ireland launched in 2025, Irish audiences proved to have a taste for the global hit reality show. This Bank Holiday Monday fans can indulge e...
01/06/2026
In its sixth year, the broadcaster's coverage has become a global brand and ...
01/06/2026
Designed to solve a common problem in broadcasting, the automated workflow detects, identifies, removes, and documents copyrighted music
AudioShake has introdu...
01/06/2026
The sports-analytics company combines its data with proprietary AI to help leagu...
01/06/2026
Category line-up & sponsors announced
Photo: Paul Clarke
The Production Music Awards (PMA) have announced that submissions are now officially open ahead of...
01/06/2026
New hybrid sample/synthesis instrument revealed
Excite Audio have just released the latest instalment in their Evolve series, which has been developed in co...
01/06/2026
Latest TONEX expansion captures three rare vintage amps
The newest addition to IK Multimedia's ever-growing TONEX line-up introduces a set of three incr...
01/06/2026
Musically intelligent soft synth gets upgraded
Scaler Music will be probably be best known to many for their music theory tools, but their product range al...
01/06/2026
SBS confirms its broadcast sponsors for FIFA World Cup 2026
1 June, 2026
Media releases
SBS has secured Hyundai, Hisense, Macca's, Rexona, bet365, Com...
01/06/2026
Rohde & Schwarz Satellite Industry Days 2026 guided by the motto From Earth to ...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Marshall Electronics is showcasing a comprehensive lineup of next-generation POV cameras, purpose-built to power today's connected AV environments, at InfoC...
01/06/2026
Adobe Announces Concept to Vector
Deepa Subramaniam June 1, 2026
0 Comments
One of the biggest frustrations we hear from designers is how difficult it...
01/06/2026
Vampire Feature Night Patrol Graded with DaVinci Resolve Studio
Brie Clayton June 1, 2026
0 Comments
Colorist shapes dark, gritty tone for horror thri...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
01/06/2026
Back to All News
KAULITZ & KAULITZ Season 3
Entertainment
01 June 2026
GlobalGermany
Link copied to clipboard
Our favorite twins are back: streaming on Ne...
01/06/2026
Luxembourg, June 1, 2026 - SES, a leading space solutions company, and Viva, Mexico's ultra low-cost airline, launched fast and reliable multi-orbit satelli...
01/06/2026
Agentic AI is getting physical.
At COMPUTEX on Tuesday, NVIDIA announced NVIDIA JetPack 7.2 and NVIDIA NemoClaw support on NVIDIA Jetson.
JetPack 7.2 brings a...
01/06/2026
Financial institutions have spent years building AI: fraud models, credit models...
01/06/2026
Mardi 2 juin 14h00
FilmLight (ARRI), 10 rue Ren Boulanger, 75010 Paris
Rejoignez-nous pour d couvrir comment FLAPI (l'API FilmLight) peut transformer e...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
Scripps Research scientists receive up to $12M to create universal vaccine for alphaviruses Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S.
